Calcium Phosphate Metabolism – Regulation and Disorders

What is Calcium Phosphate Metabolism?

Calcium phosphate metabolism refers to the complex set of biological processes that regulate the levels of calcium and phosphate in the blood, bones, and other tissues. These two minerals are closely interrelated: they coexist within the bone matrix, influence each other's absorption and excretion, and are controlled by the same hormones. Disruptions in calcium phosphate metabolism can lead to a wide range of conditions, including osteoporosis, kidney disease, and neurological disorders.

Biological Importance of Calcium and Phosphate

Calcium is the most abundant mineral in the human body. Approximately 99% of all calcium is stored in the bones and teeth. The remaining 1% circulates in the blood and soft tissues, where it fulfils vital functions:

• Structural integrity of bones and teeth
• Transmission of nerve impulses and muscle contraction
• Blood clotting
• Intracellular signalling

Phosphate is equally essential. About 85% of the body's phosphate is located in the bones. Phosphate is also a component of ATP (the cellular energy currency), DNA, RNA, and cell membranes. It plays a critical role in energy metabolism and the regulation of acid-base balance.

Hormonal Regulation

Calcium phosphate metabolism is controlled by a precise hormonal system. The three primary regulators are:

Parathyroid Hormone (PTH)

Parathyroid hormone (PTH) is secreted by the parathyroid glands when blood calcium levels fall. It acts on three levels:

• Kidneys: Promotes calcium reabsorption while inhibiting phosphate reabsorption, leading to increased urinary phosphate excretion.
• Bone: Stimulates bone resorption (osteoclast activity), releasing calcium and phosphate into the bloodstream.
• Intestine: Indirectly enhances calcium absorption by activating vitamin D synthesis in the kidneys.

Vitamin D (Calcitriol)

Calcitriol is the biologically active form of vitamin D. It is synthesised in the skin under UV radiation and converted to its active form in the liver and kidneys. Calcitriol:

• Promotes the absorption of calcium and phosphate in the small intestine
• Supports bone mineralisation
• Suppresses PTH secretion via negative feedback

Calcitonin

Calcitonin is produced by the thyroid gland in response to elevated blood calcium levels. It lowers calcium by inhibiting bone resorption and increasing renal calcium excretion. Its physiological role in adults is considered less significant than that of PTH and vitamin D, but it plays a role in regulating calcium after calcium-rich meals.

FGF-23 (Fibroblast Growth Factor 23)

FGF-23 is a hormone produced by bone cells (osteocytes). It lowers blood phosphate levels by increasing renal phosphate excretion and inhibiting vitamin D activation. FGF-23 plays a central role in chronic kidney disease, where its levels are often markedly elevated.

Organs Involved in Calcium Phosphate Metabolism

Intestine

In the small intestine, calcium is absorbed through two mechanisms: an active, vitamin-D-dependent transport system and passive paracellular diffusion. The efficiency of calcium absorption depends strongly on vitamin D levels, dietary intake, and current physiological demand. Phosphate is also actively absorbed in the gut, though high calcium concentrations can inhibit phosphate uptake.

Kidneys

The kidneys are the central organ of fine-tuning. They filter large amounts of calcium and phosphate daily, most of which is reabsorbed. Excretion rates are precisely regulated by PTH, calcitriol, and FGF-23. Impaired kidney function can significantly disrupt overall mineral balance.

Bone

Bone acts as a reservoir and buffer organ. It releases calcium and phosphate into the blood when needed and takes them up again when supply is sufficient. The balance between bone formation (by osteoblasts) and bone resorption (by osteoclasts) is regulated by hormones and local factors.

Disorders of Calcium Phosphate Metabolism

Diseases of calcium phosphate metabolism can arise from overactivity or underactivity of the regulating hormones or from organ dysfunction:

• Hypocalcaemia: Abnormally low blood calcium, which can cause muscle cramps (tetany), tingling, and in severe cases cardiac arrhythmias. Causes include hypoparathyroidism and vitamin D deficiency.
• Hypercalcaemia: Elevated blood calcium, often due to primary hyperparathyroidism or malignancy. Symptoms include nausea, fatigue, kidney stones, and in severe cases confusion or impaired consciousness.
• Hyperphosphataemia: Elevated phosphate levels, frequently seen in chronic kidney insufficiency. Associated with vascular calcification and increased cardiovascular risk.
• Hypophosphataemia: Low phosphate levels, which may result from malnutrition, malabsorption, or genetic disorders. Causes muscle weakness, bone pain, and in severe cases respiratory failure.
• Renal osteodystrophy: A complex bone metabolism disorder arising from disrupted vitamin D and PTH balance in chronic kidney disease.
• Rickets / Osteomalacia: Caused by vitamin D deficiency, leading to inadequate bone mineralisation. In children it is called rickets; in adults it is referred to as osteomalacia.

Diagnosis

Disorders of calcium phosphate metabolism are diagnosed through:

• Blood tests: total and ionised calcium, phosphate, PTH, vitamin D (25-OH-D and 1,25-OH-D), FGF-23, albumin, creatinine
• Urine tests: 24-hour urinary calcium and phosphate excretion
• Imaging: bone density scan (DXA), X-rays of the skeleton
• Genetic testing when hereditary disorders are suspected

Treatment

Treatment is directed at the underlying cause and may include:

• Vitamin D supplementation in cases of deficiency or impaired activation
• Calcium supplements for hypocalcaemia
• Phosphate binders for hyperphosphataemia (e.g. in renal insufficiency)
• PTH analogues or calcimimetics for parathyroid disorders
• Dialysis or kidney transplantation in end-stage renal disease with severe mineral imbalance
• Dietary adjustments, such as calcium-rich or low-phosphate diets

References

1. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and Disorders of Mineral Metabolism. In: Williams Textbook of Endocrinology, 14th ed. Elsevier, 2020.
2. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1-59.
3. World Health Organization (WHO). Calcium and Magnesium in Drinking Water: Public Health Significance. WHO Press, Geneva, 2009.